More importantly, a novel ferroptosis-based prognostic molecular signature of PCa based on four FRGs (including ASNS, GPT2, NFE2L2, RRM2) was developed, which has the great performance for predicting BCRFS. The gene discussed is NFE2L2; the disease is posterior cortical atrophy.